Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (191-200 of 436) with videos related to

Pageof 44
Sort By:
Archives of Internal Medicine|November 26, 2003
Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patientsMichael A Fischer, Daniel H Solomon, Jonathan M Teich, et al.
The American Journal of Cardiology|August 14, 2003
Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectorisAkshay S Desai, Daniel H Solomon, Peter H Stone, et al.
Plos One|March 28, 2014
Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysisKrista F Huybrechts, Reesha Shah Sanghani, Jerry Avorn, et al.
JAMA|September 24, 2014
Electronic medication packaging devices and medication adherence: a systematic reviewKyle D Checchi, Krista F Huybrechts, Jerry Avorn, et al.
JAMA Internal Medicine|May 22, 2023
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance InhalersWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim, et al.
BMJ Open|February 15, 2018
Adaptive design clinical trials: a review of the literature and ClinicalTrials.govLaura E Bothwell, Jerry Avorn, Nazleen F Khan, et al.
Circulation|December 21, 2006
Statins and the risk of lung, breast, and colorectal cancer in the elderlySoko Setoguchi, Robert J Glynn, Jerry Avorn, et al.
Archives of Internal Medicine|April 25, 2007
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patientsMichael A Fischer, Charles A Morris, Wolfgang C Winkelmayer, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Statin lipid-lowering drugs and bone mineral densityDaniel H Solomon, Joel S Finkelstein, Philip S Wang, et al.
Pharmacoeconomics|October 27, 2007
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysisAmanda R Patrick, Wolfgang C Winkelmayer, Jerry Avorn, et al.
Pageof 44

Showing results (191-200 of 436) with videos related to

Sort By:
Pageof 44
Archives of Internal Medicine|November 26, 2003
Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patientsMichael A Fischer, Daniel H Solomon, Jonathan M Teich, et al.
The American Journal of Cardiology|August 14, 2003
Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectorisAkshay S Desai, Daniel H Solomon, Peter H Stone, et al.
Plos One|March 28, 2014
Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysisKrista F Huybrechts, Reesha Shah Sanghani, Jerry Avorn, et al.
JAMA|September 24, 2014
Electronic medication packaging devices and medication adherence: a systematic reviewKyle D Checchi, Krista F Huybrechts, Jerry Avorn, et al.
JAMA Internal Medicine|May 22, 2023
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance InhalersWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim, et al.
BMJ Open|February 15, 2018
Adaptive design clinical trials: a review of the literature and ClinicalTrials.govLaura E Bothwell, Jerry Avorn, Nazleen F Khan, et al.
Circulation|December 21, 2006
Statins and the risk of lung, breast, and colorectal cancer in the elderlySoko Setoguchi, Robert J Glynn, Jerry Avorn, et al.
Archives of Internal Medicine|April 25, 2007
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patientsMichael A Fischer, Charles A Morris, Wolfgang C Winkelmayer, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Statin lipid-lowering drugs and bone mineral densityDaniel H Solomon, Joel S Finkelstein, Philip S Wang, et al.
Pharmacoeconomics|October 27, 2007
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysisAmanda R Patrick, Wolfgang C Winkelmayer, Jerry Avorn, et al.
Pageof 44